| Nathan E Hoffmann, MD | |
|
400 East 3rd Street, Smdc Medical Center-duluth Clinic, Duluth, MN 55805 | |
| (218) 786-3234 | |
| Not Available |
| Full Name | Nathan E Hoffmann |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 21 Years |
| Location | 400 East 3rd Street, Duluth, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134106982 | NPI | - | NPPES |
| 951492900 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 46757 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Essentia Health Duluth | Duluth, MN | Hospital |
| Essentia Health Virginia | Virginia, MN | Hospital |
| St Marys Hospital Superior | Superior, WI | Hospital |
| Essentia Health St Mary's Medical Center | Duluth, MN | Hospital |
| Essentia Health Northern Pines Medical Center | Aurora, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Duluth Clinic Ltd | 2567374283 | 932 |
News Archive
A unique gene-editing method that efficiently inserts DNA into genes located in dividing and non-dividing cells of living rats has been developed by a team of international researchers, including scientists from KAUST.
Using several large datasets describing health care visits, geographic movements and demographics of more than 150 million people over nine years, researchers at the University of Chicago have created models that predict the spread of influenza throughout the United States each year.
Pernix Therapeutics Holdings, Inc. (NYSE Amex: PTX), a specialty pharmaceutical company, today announced the introduction of Omeclamox-Pak®, a ten-day therapy of omeprazole delayed-release capsules (20 mg), clarithromycin tablets (500 mg) and amoxicillin capsules (500 mg) for the treatment of Helicobacter pylori (H. pylori) infection and duodenal ulcer disease (active or one-year history) to eradicate H. pylori in adult patients.
News stories look at who wins and who loses under the health law. Elsewhere, Obamacare message sparring gets personal.
A new UC Irvine study sheds light on how HIV develops into AIDS and suggests a possible way to block the deadly transformation.
› Verified 3 days ago
| Entity Name | The Duluth Clinic Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902563638 PECOS PAC ID: 2567374283 Enrollment ID: O20031103000229 |
News Archive
A unique gene-editing method that efficiently inserts DNA into genes located in dividing and non-dividing cells of living rats has been developed by a team of international researchers, including scientists from KAUST.
Using several large datasets describing health care visits, geographic movements and demographics of more than 150 million people over nine years, researchers at the University of Chicago have created models that predict the spread of influenza throughout the United States each year.
Pernix Therapeutics Holdings, Inc. (NYSE Amex: PTX), a specialty pharmaceutical company, today announced the introduction of Omeclamox-Pak®, a ten-day therapy of omeprazole delayed-release capsules (20 mg), clarithromycin tablets (500 mg) and amoxicillin capsules (500 mg) for the treatment of Helicobacter pylori (H. pylori) infection and duodenal ulcer disease (active or one-year history) to eradicate H. pylori in adult patients.
News stories look at who wins and who loses under the health law. Elsewhere, Obamacare message sparring gets personal.
A new UC Irvine study sheds light on how HIV develops into AIDS and suggests a possible way to block the deadly transformation.
› Verified 3 days ago
| Entity Name | Essentia Health Moose Lake |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154959880 PECOS PAC ID: 6608290333 Enrollment ID: O20200730001548 |
News Archive
A unique gene-editing method that efficiently inserts DNA into genes located in dividing and non-dividing cells of living rats has been developed by a team of international researchers, including scientists from KAUST.
Using several large datasets describing health care visits, geographic movements and demographics of more than 150 million people over nine years, researchers at the University of Chicago have created models that predict the spread of influenza throughout the United States each year.
Pernix Therapeutics Holdings, Inc. (NYSE Amex: PTX), a specialty pharmaceutical company, today announced the introduction of Omeclamox-Pak®, a ten-day therapy of omeprazole delayed-release capsules (20 mg), clarithromycin tablets (500 mg) and amoxicillin capsules (500 mg) for the treatment of Helicobacter pylori (H. pylori) infection and duodenal ulcer disease (active or one-year history) to eradicate H. pylori in adult patients.
News stories look at who wins and who loses under the health law. Elsewhere, Obamacare message sparring gets personal.
A new UC Irvine study sheds light on how HIV develops into AIDS and suggests a possible way to block the deadly transformation.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nathan E Hoffmann, MD 400 East 3rd Street, Smdc Medical Center-duluth Clinic, Duluth, MN 55805 Ph: (218) 786-3234 | Nathan E Hoffmann, MD 400 East 3rd Street, Smdc Medical Center-duluth Clinic, Duluth, MN 55805 Ph: (218) 786-3234 |
News Archive
A unique gene-editing method that efficiently inserts DNA into genes located in dividing and non-dividing cells of living rats has been developed by a team of international researchers, including scientists from KAUST.
Using several large datasets describing health care visits, geographic movements and demographics of more than 150 million people over nine years, researchers at the University of Chicago have created models that predict the spread of influenza throughout the United States each year.
Pernix Therapeutics Holdings, Inc. (NYSE Amex: PTX), a specialty pharmaceutical company, today announced the introduction of Omeclamox-Pak®, a ten-day therapy of omeprazole delayed-release capsules (20 mg), clarithromycin tablets (500 mg) and amoxicillin capsules (500 mg) for the treatment of Helicobacter pylori (H. pylori) infection and duodenal ulcer disease (active or one-year history) to eradicate H. pylori in adult patients.
News stories look at who wins and who loses under the health law. Elsewhere, Obamacare message sparring gets personal.
A new UC Irvine study sheds light on how HIV develops into AIDS and suggests a possible way to block the deadly transformation.
› Verified 3 days ago
Nicholas Kahlert Johnson, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1001 E Superior St, Ste. L201, Duluth, MN 55802 Phone: 218-249-7980 Fax: 218-249-7911 | |
Dr. Elizabeth Barbara Johnson, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1001 E Superior St, Ste. L201, Duluth, MN 55802 Phone: 218-249-7980 Fax: 218-249-7911 | |
Matthew A Emme, MD Urology Medicare: Medicare Enrolled Practice Location: 1001 E Superior St, Ste. L201, Duluth, MN 55802 Phone: 218-249-7980 Fax: 218-249-7911 | |
Carrie Ronstrom, MD Urology Medicare: Medicare Enrolled Practice Location: 1001 E Superior St Ste 201, Duluth, MN 55802 Phone: 218-249-5555 | |
Jeffrey Scott Engelsgjerd, Urology Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 | |
Rebekah Beach, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1001 E Superior St, Suite L201, Duluth, MN 55802 Phone: 218-249-7980 |